ARCHIVES

Combined analysis moves Herceptin to adjuvant setting in breast cancer.

This article is from The Cancer Letter archive.

Vol. 31 No. 21 | May 27, 2005

Download PDF Visit The Full Archive

Related Articles

Women Who Concieve Using Fertility Drugs Have a Higher Risk Of Breast Cancer Than Non-Users

July 27, 2012

Cooperative Group Chairmen Unhappy Over Contracts They Missed, NCI Protocol Review

January 13, 1978

BSA Approves Six Concepts

July 19, 2013

Study Shows Early Treatment Of Asymptomatic Myeloma Can Improve Survival

August 30, 2013

Pathology In Operating Suite Cuts Need for More Surgery

February 24, 2012

Funding Opportunities: NCI Request for Applications

April 28, 2000